The Department of Oncology was established in 1988. It is a comprehensive oncology diagnosis and treatment discipline integrating early tumor biopsy, minimally invasive tumor therapy, radiotherapy, chemotherapy, targeted therapy, and biological therapy.
The department has currently formed three subspecialties: radiation oncology, medical oncology (chemotherapy), and minimally invasive tumor therapy. In 2006, it was awarded a master’s degree training program in oncology by the Ministry of Education. In 2008 and 2012, it was designated by the Shandong Provincial Department of Health as a Shandong Provincial Continuing Education and Training Base for Comprehensive Oncology Treatment and Minimally Invasive Treatment, respectively. In 2013, it was awarded the title of Unit with Capability for Minimally Invasive Tumor Ablation Therapy by the Shandong Provincial Health and Family Planning Commission, and was designated as a Provincial Standardized Cancer Pain Treatment Demonstration Ward. In 2014, it was designated by the Shandong Provincial Health and Family Planning Commission as a Standardized Residency Training Base for Radiation Oncology and a Standardized Training Base for Oncology Nurses. In 2015, it was designated as a Clinical Key Specialty Construction Unit by the Shandong Provincial Health Commission. In 2018, it was rated as a Shandong Provincial Standardized Tumor Treatment Ward by the Shandong Provincial Health Commission. In 2019, it was designated as a Clinical Drug Trial Base by the National Medical Products Administration. In 2020, it was designated as a Clinical Key Specialty by the Shandong Provincial Health Commission. The hospital has explicitly identified the Department of Oncology as a key development discipline in its 13th Five-Year Plan, striving to develop it into a clinically distinctive diagnosis and treatment research center that drives the development of regional key disciplines.
The Department of Oncology currently has 120 beds, three wards, a radiotherapy center, a large-bore CT diagnostic and treatment room, and a PICC catheter technique room. The department has a first-class medical expert team in the province, including 30 physicians—3 chief physicians, 2 associate chief physicians, 10 attending physicians, and 15 resident physicians—and 10 radiotherapy technicians. The department is equipped with 2 medical linear accelerators, 1 large-bore CT, 1 simulator, 1 tumor ablation machine, 1 color ultrasound machine, 2 biopsy guns, and other equipment. It mainly provides radiotherapy, chemotherapy (including chemotherapeutic drugs, molecular targeted drugs, and immunotherapy), ablation therapy, early tumor screening, and percutaneous biopsy techniques. At the same time, the department has established a multidisciplinary team (MDT) consultation and treatment system for tumors, ensuring the best and most effective treatment for every patient with cancer.
The Department of Oncology undertakes clinical teaching for Shandong First Medical University, teaching and supervision of master’s degree students, teaching at the School of Foreign Languages, and clinical supervision at the School of Nursing. It has undertaken more than 20 research projects approved by the Ministry of Science and Technology, the Provincial Health Commission, and the Tai’an Municipal Science and Technology Bureau. It has undertaken nearly 10 or more continuing education projects of the Shandong Provincial Health Commission and national continuing education projects. At the same time, it serves as the chair unit of the Tumor Minimally Invasive Treatment Committee and the Tumor Palliative Care Committee of the Tai’an Medical Association, and is the lead unit of the Tumor Minimally Invasive Diagnosis and Treatment Technology Alliance led by the Second Affiliated Hospital of Shandong First Medical University and awarded by the Tai’an Municipal Health Commission. It has published more than 150 papers in national journals, applied for 16 national patents, completed 13 provincial, departmental, and municipal projects, published 7 monographs and textbooks, and hosted more than 10 provincial and municipal academic conferences.
Telephone: 0538-6232658 (Oncology Ward I); 0538-6236830 (Oncology Ward II).